MedTrace Logo

The CHYMASE Angiotensin-(1-12) Axis in Cardiovascular Disease

NCT03826745 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2019-09-12

No results posted yet for this study

Summary

Study is to evaluate the Chymase Angiotensin-(1-12) in cardiovascular disease

Conditions

Interventions

OTHER

Plasma/Urine

Plasma of normal male and female normotensive, hypertensive, and/or resistant hypertensive subjects.

Sponsors & Collaborators

  • Wake Forest University

    collaborator OTHER

  • Trinity Hypertension & Metabolic Research Institute

    lead OTHER

Principal Investigators

  • Henry A Punzi, MD · Punzi Medical Center

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-11
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03826745 on ClinicalTrials.gov